Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Administering your injection in the morning rather than the evening helps avoid nausea and GI discomfort at night, improving your sleep quality
I have not been using it yet in my clinic
Naturally, our number of participants returning for follow-up appointments and lab draws decreased over the course of the study
Book your consultation today.
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
The clinical dosage range spans 2.510 mg per subcutaneous injection, titrated over 4 weeks before reaching a maintenance dose of 510 mg, five times weekly
US$ 21.67
US$ 27.44
US$ 27.25
